Gynecologic Cancer
Conference Coverage
Veliparib improves PFS in high-grade serous epithelial ovarian cancer
BARCELONA – Adding veliparib to frontline CT and maintenance significantly extended PFS in women with high-grade...
How I will treat my next patient
The law of unintended consequences
Dr. Alan P. Lyss examines the impact of women’s health clinic closures and excessive radiation doses in some lung cancer screening programs.
From the Journals
Pilot program benefits gynecologic cancer patients with malignant bowel obstruction
Among patients with advanced gynecologic cancer and malignant bowel obstruction, hospital length of stay decreased after the implementation of a...
Conference Coverage
PRIMA study: Niraparib maintenance improves PFS in advanced OC
BARCELONA – Niraparib improves PFS when given after first-line chemotherapy for advanced ovarian cancer, according...
Conference Coverage
PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer
BARCELONA – Benefit was particularly pronounced in patients with a tumor BRCA mutation and those with homologous recombination deficiency (HRD)–...
Conference Coverage
BAROCCO study: Cediranib-olaparib combination shows promise in PROC
BARCELONA –
Conference Coverage
Closure of women’s health clinics may negatively impact cervical cancer outcomes
Mortality risk among women with cervical cancer was 36% higher in states that had a decreased number of women’s clinics.
News
FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma
The approval is based on positive results from the KEYNOTE-146 trial.
From the Journals
Nivolumab may be beneficial for recurrent or metastatic cervical cancer
Study results underscore the growing role of immune checkpoint inhibitors in virus-associated cancers.
From the Journals
Perceived discrimination linked to delay in ovarian cancer diagnosis for black women
In a case-control analysis, researchers found that every 1-unit rise in the frequency of everyday discrimination was associated with a higher...
Opinion
Ovarian cancer and perineal talc exposure: An epidemiologic dilemma
Recall bias and lack of an established biologic mechanism are a few reasons perineal talc exposure isn’t considered a definitive cause of ovarian...